BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24666391)

  • 1. In vivo opioid receptor heteromerization: where do we stand?
    Massotte D
    Br J Pharmacol; 2015 Jan; 172(2):420-34. PubMed ID: 24666391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
    Fujita W; Gomes I; Devi LA
    Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.
    Fujita W; Gomes I; Devi LA
    Br J Pharmacol; 2014 Sep; 171(18):4155-76. PubMed ID: 24916280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities.
    Gaborit M; Massotte D
    Br J Pharmacol; 2023 Apr; 180(7):994-1013. PubMed ID: 34883528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor trafficking and interaction in nociceptors.
    Zhang X; Bao L; Li S
    Br J Pharmacol; 2015 Jan; 172(2):364-74. PubMed ID: 24611685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-receptor-heteromer-specific trafficking and pharmacology.
    van Rijn RM; Whistler JL; Waldhoer M
    Curr Opin Pharmacol; 2010 Feb; 10(1):73-9. PubMed ID: 19846340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic synergy between opioid and α2 -adrenoceptors.
    Chabot-Doré AJ; Schuster DJ; Stone LS; Wilcox GL
    Br J Pharmacol; 2015 Jan; 172(2):388-402. PubMed ID: 24641506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel GPCR paradigms at the μ-opioid receptor.
    Thompson GL; Kelly E; Christopoulos A; Canals M
    Br J Pharmacol; 2015 Jan; 172(2):287-96. PubMed ID: 24460711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges for opioid receptor nomenclature: IUPHAR Review 9.
    Cox BM; Christie MJ; Devi L; Toll L; Traynor JR
    Br J Pharmacol; 2015 Jan; 172(2):317-23. PubMed ID: 24528283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances on the δ opioid receptor: from trafficking to function.
    Gendron L; Mittal N; Beaudry H; Walwyn W
    Br J Pharmacol; 2015 Jan; 172(2):403-19. PubMed ID: 24665909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying ligand-specific signalling within biased responses: focus on δ opioid receptor ligands.
    Charfi I; Audet N; Bagheri Tudashki H; Pineyro G
    Br J Pharmacol; 2015 Jan; 172(2):435-48. PubMed ID: 24665881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures.
    Marino KA; Shang Y; Filizola M
    Br J Pharmacol; 2018 Jul; 175(14):2834-2845. PubMed ID: 28266020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The μ-opioid receptor: an electrophysiologist's perspective from the sharp end.
    Henderson G
    Br J Pharmacol; 2015 Jan; 172(2):260-7. PubMed ID: 24640948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation.
    Mann A; Illing S; Miess E; Schulz S
    Br J Pharmacol; 2015 Jan; 172(2):311-6. PubMed ID: 24517854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of δ-opioid receptors in learning and memory underlying the development of addiction.
    Klenowski P; Morgan M; Bartlett SE
    Br J Pharmacol; 2015 Jan; 172(2):297-310. PubMed ID: 24641428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-dependent and abstinent mice are characterized by a broader distribution of the neurons co-expressing mu and delta opioid receptors.
    Pierre F; Ugur M; Faivre F; Doridot S; Veinante P; Massotte D
    Neuropharmacology; 2019 Jul; 152():30-41. PubMed ID: 30858104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.
    Burford NT; Traynor JR; Alt A
    Br J Pharmacol; 2015 Jan; 172(2):277-86. PubMed ID: 24460691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteromerization Modulates mu Opioid Receptor Functional Properties
    Ugur M; Derouiche L; Massotte D
    Front Pharmacol; 2018; 9():1240. PubMed ID: 30483121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor heteromers in analgesia.
    Costantino CM; Gomes I; Stockton SD; Lim MP; Devi LA
    Expert Rev Mol Med; 2012 Apr; 14():e9. PubMed ID: 22490239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).
    Knapman A; Connor M
    Br J Pharmacol; 2015 Jan; 172(2):349-63. PubMed ID: 24527749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.